Gong E - Search Results

1

Genomic interval engineering of mice identifies a novel modulator of triglyceride production.

Zhu Y, Jong MC, Frazer KA, Gong E, Krauss RM, Cheng JF, Boffelli D, Rubin EM. Zhu Y, et al. Among authors: gong e. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1137-42. doi: 10.1073/pnas.97.3.1137. Proc Natl Acad Sci U S A. 2000. PMID: 10655497 Free PMC article.

2

Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.

Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA. Visel A, et al. Among authors: gong e. Nature. 2010 Mar 18;464(7287):409-12. doi: 10.1038/nature08801. Epub 2010 Feb 21. Nature. 2010. PMID: 20173736 Free PMC article.

3

Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.

Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Schultz JR, et al. Among authors: gong el. Nature. 1993 Oct 21;365(6448):762-4. doi: 10.1038/365762a0. Nature. 1993. PMID: 8413656

4

Microarray expression profiling identifies genes with altered expression in HDL-deficient mice.

Callow MJ, Dudoit S, Gong EL, Speed TP, Rubin EM. Callow MJ, et al. Among authors: gong el. Genome Res. 2000 Dec;10(12):2022-9. doi: 10.1101/gr.10.12.2022. Genome Res. 2000. PMID: 11116096 Free PMC article.

5

Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice.

Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, Francone O, Rubin EM. Ueda Y, et al. Among authors: gong e. J Biol Chem. 1999 Mar 12;274(11):7165-71. doi: 10.1074/jbc.274.11.7165. J Biol Chem. 1999. PMID: 10066776 Free article.

6

Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics.

Ueda Y, Gong E, Royer L, Cooper PN, Francone OL, Rubin EM. Ueda Y, et al. Among authors: gong e. J Biol Chem. 2000 Jul 7;275(27):20368-73. doi: 10.1074/jbc.M000730200. J Biol Chem. 2000. PMID: 10751392 Free article.

7

Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.

Schultz JR, Gong EL, McCall MR, Nichols AV, Clift SM, Rubin EM. Schultz JR, et al. Among authors: gong el. J Biol Chem. 1992 Oct 25;267(30):21630-6. J Biol Chem. 1992. PMID: 1400473 Free article.

8

Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.

Gong EL, Stoltfus LJ, Brion CM, Murugesh D, Rubin EM. Gong EL, et al. J Biol Chem. 1996 Mar 15;271(11):5984-7. doi: 10.1074/jbc.271.11.5984. J Biol Chem. 1996. PMID: 8626380 Free article.

9

Structural and functional properties of human and mouse apolipoprotein A-I.

Gong EL, Tan CS, Shoukry MI, Rubin EM, Nichols AV. Gong EL, et al. Biochim Biophys Acta. 1994 Aug 4;1213(3):335-42. doi: 10.1016/0005-2760(94)00062-x. Biochim Biophys Acta. 1994. PMID: 8049247

10

Increased low density lipoprotein degradation in aorta of irradiated mice is inhibited by preenrichment of low density lipoprotein with alpha-tocopherol.

Tribble DL, Krauss RM, Chu BM, Gong EL, Kullgren BR, Nagy JO, La Belle M. Tribble DL, et al. Among authors: gong el. J Lipid Res. 2000 Oct;41(10):1666-72. J Lipid Res. 2000. PMID: 11013309 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters